Nomination Committee Appointed for Polymer Factory’s Annual General Meeting 2026
29 december, 2025
29 december, 2025
Nomination Committee Appointed for Polymer Factory’s Annual General Meeting 2026
The Nomination Committee of Polymer Factory, appointed in accordance with the principles adopted at the Annual General Meeting held on June 3, 2025, consists of the following members:
The Nomination Committee shall, ahead of the Annual General Meeting 2026, prepare proposals regarding the election of the Chair of the Board and other Board members, the Chair of the Annual General Meeting, the auditor, remuneration to the Board of Directors, and other related matters.
Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2026 may do so by e-mail to investor@polymerfactory.com or by regular mail to the company. Proposals must be submitted to the Nomination Committee no later than February 28, 2026.
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.
For more information, please contact:
Mats Wallnér, Acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
29 december, 2025
Nomination Committee Appointed for Polymer Factory’s Annual General Meeting 2026
The Nomination Committee of Polymer Factory, appointed in accordance with the principles adopted at the Annual General Meeting held on June 3, 2025, consists of the following members:
The Nomination Committee shall, ahead of the Annual General Meeting 2026, prepare proposals regarding the election of the Chair of the Board and other Board members, the Chair of the Annual General Meeting, the auditor, remuneration to the Board of Directors, and other related matters.
Shareholders who wish to submit proposals to the Nomination Committee ahead of the Annual General Meeting 2026 may do so by e-mail to investor@polymerfactory.com or by regular mail to the company. Proposals must be submitted to the Nomination Committee no later than February 28, 2026.
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.
For more information, please contact:
Mats Wallnér, Acting CEO
Phone: +46 (0) 70 951 95 06
E-mail: mats.wallner@polymerfactory.com
Ericsson
Rapporter
Analyser
Aktierekommendationer
Investor
Aktier
Ministrarnas innehav
Ericsson
Rapporter
Analyser
Aktierekommendationer
Investor
Aktier
Ministrarnas innehav
Essity
Igår, 15:27
Industrivärden köper aktier i Essity
OMX Stockholm 30
1 DAG %
Senast
3 013,63
